Cvitkovic E - Search Results

1

Nasopharyngeal cancer: epidemiology, staging, and treatment.

Fandi A, Altun M, Azli N, Armand JP, Cvitkovic E. Fandi A, et al. Among authors: cvitkovic e. Semin Oncol. 1994 Jun;21(3):382-97. Semin Oncol. 1994. PMID: 8209270 Review. No abstract available.

2

Undifferentiated carcinoma of nasopharyngeal type of tonsil.

Klijanienko J, Micheau C, Azli N, Cvitkovic E, Eschwege F, Marandas P, Armand JP, Casiraghi O, Schwaab G, de Vathaire F. Klijanienko J, et al. Among authors: cvitkovic e. Arch Otolaryngol Head Neck Surg. 1989 Jun;115(6):731-4. doi: 10.1001/archotol.1989.01860300085023. Arch Otolaryngol Head Neck Surg. 1989. PMID: 2541744

3

Biology and treatment of nasopharyngeal cancer.

Fandi A, Cvitkovic E. Fandi A, et al. Among authors: cvitkovic e. Curr Opin Oncol. 1995 May;7(3):255-63. doi: 10.1097/00001622-199505000-00011. Curr Opin Oncol. 1995. PMID: 7654828 Review.

4

Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases.

Cvitkovic E, Bachouchi M, Boussen H, Busson P, Rousselet G, Mahjoubi R, Flores P, Tursz T, Armand JP, Azli N. Cvitkovic E, et al. J Clin Oncol. 1993 Dec;11(12):2434-42. doi: 10.1200/JCO.1993.11.12.2434. J Clin Oncol. 1993. PMID: 8246032

5

Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type.

Fandi A, Taamma A, Azli N, Bachouchi M, Yanes B, Armand JP, Cvitkovic E. Fandi A, et al. Among authors: cvitkovic e. Head Neck. 1997 Jan;19(1):41-7. doi: 10.1002/(sici)1097-0347(199701)19:1<41::aid-hed8>3.0.co;2-v. Head Neck. 1997. PMID: 9030944 Clinical Trial.

6

Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.

Azli N, Fandi A, Bachouchi M, Rahal M, Lianes P, Wibault P, Boussen H, Eschwege F, Armand JP, Cvitkovic E. Azli N, et al. Among authors: cvitkovic e. Cancer J Sci Am. 1995 Sep-Oct;1(3):222-9. Cancer J Sci Am. 1995. PMID: 9166480 Clinical Trial.

7

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type.

Hasbini A, Mahjoubi R, Fandi A, Chouaki N, Taamma A, Lianes P, Cortès-Funes H, Alonso S, Armand JP, Cvitkovic E, Raymond E. Hasbini A, et al. Among authors: cvitkovic e. Ann Oncol. 1999 Apr;10(4):421-5. doi: 10.1023/a:1008342828496. Ann Oncol. 1999. PMID: 10370784 Free article. Clinical Trial.

8

Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type.

Fandi A, Bachouchi M, Azli N, Taamma A, Boussen H, Wibault P, Eschwege F, Armand JP, Simon J, Cvitkovic E. Fandi A, et al. Among authors: cvitkovic e. J Clin Oncol. 2000 Mar;18(6):1324-30. doi: 10.1200/JCO.2000.18.6.1324. J Clin Oncol. 2000. PMID: 10715304

9

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.

Boussen H, Cvitkovic E, Wendling JL, Azli N, Bachouchi M, Mahjoubi R, Kalifa C, Wibault P, Schwaab G, Armand JP. Boussen H, et al. Among authors: cvitkovic e. J Clin Oncol. 1991 Sep;9(9):1675-81. doi: 10.1200/JCO.1991.9.9.1675. J Clin Oncol. 1991. PMID: 1714951 Clinical Trial.

10

Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications.

Cvitkovic E, Bachouchi M, Armand JP. Cvitkovic E, et al. Hematol Oncol Clin North Am. 1991 Aug;5(4):821-38. Hematol Oncol Clin North Am. 1991. PMID: 1890068 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters